サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1572019

椎体形成術の世界市場

Vertebroplasty

出版日
ページ情報
英文 93 Pages
納期
即日から翌営業日
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.99円
椎体形成術の世界市場
出版日: 2024年10月18日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 93 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

椎体形成術の世界市場は2030年までに4億2,670万米ドルに達する見込み

2023年に2億8,750万米ドルと推定される椎体形成術の世界市場は、2030年には4億2,670万米ドルに達し、分析期間2023-2030年のCAGRは5.8%で成長すると予測されます。

米国市場は7,630万米ドルと推定、中国はCAGR 8.5％で成長予測

米国の椎体形成術市場は、2023年に7,630万米ドルと推定されます。世界第2位の経済大国である中国は、2023年から2030年の分析期間においてCAGR 8.5%で推移し、2030年には予測市場規模9,530万米ドルに達すると予測されています。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ3.3％と5.5％と予測されています。欧州では、ドイツがCAGR 3.4%で成長すると予測されています。

世界の椎体形成術市場動向と促進要因まとめ

椎体形成術とは何か？

椎体形成術は、主に骨粗鬆症、転移性がん、外傷によって引き起こされる痛みを伴う椎体圧迫骨折（VCF）を治療するために開発された、最先端の低侵襲手術法です。この手術では、特殊なアクリル骨セメント（最も一般的なものはポリメチルメタクリレート（PMMA））を骨折した椎骨に直接注入することで、椎骨を安定させ、痛みを迅速に緩和します。椎体形成術の間、外科医はセメントを正確に注入するため、連続したリアルタイムの透視またはCT画像ガイダンスのもと、骨折した骨に皮膚から細い針を慎重に挿入します。セメントは半液体の状態で注入され、すぐに椎骨内で固まるので、構造的完全性を効果的に回復し、痛みの原因である微小な動きを抑えます。椎体形成術が特に魅力的なのは、痛みを即座に緩和し、持続させることができるため、術後すぐに通常の活動を再開できることです。椎体形成術は通常、安静、疼痛管理、装具などの保存的治療に反応しない患者に推奨され、衰弱性脊椎骨折患者の生活の質を向上させる重要な選択肢となっています。さらに、調査手法には確立された安全性プロファイルがあり、最近の画像診断技術、セメント組成、手技方法の進歩により、関連するリスクが大幅に軽減されたため、整形外科や神経外科の分野で広く受け入れられている治療選択肢となっています。

椎体形成術の主な利点と課題は？

椎体形成術の利点は多面的で、椎体圧迫骨折患者に大きな臨床的利益をもたらしますが、課題がないわけではありません。その主な利点のひとつは、痛みが迅速かつ大幅に軽減されることであり、多くの場合、術後数時間以内に痛みが軽減されるため、患者は従来の開腹手術による治療よりもはるかに早く可動性を回復し、日常生活に戻ることができます。このような回復の早さは、特に、身体能力に制限のある高齢の患者や、治療を複雑にする複数の合併症を患っている患者にとって極めて重要です。さらに、骨折した椎骨を安定させることで、椎体形成術は脊柱のさらなる崩壊と変形を防ぎ、一般的に"こぶ太り"として知られる後弯症の進行リスクを軽減します。このような利点があるにもかかわらず、椎体形成術は、医学界で大きな議論を巻き起こしてきました。その主な原因は、注入された材料が椎体から隣接する構造物に漏れ出し、神経根の圧迫、塞栓症、脊髄損傷を引き起こす可能性のある合併症に関する懸念です。このようなリスクを軽減するために、より粘度の高いセメントを使用したり、手技中のコントロールがしやすいように注入技術を改良したりするなど、セメント製剤の改良が進められてきました。もう一つの重要な課題は、骨折の根本的な原因によって有効性が異なるため、椎体形成術の適切な課題の選択にあります。椎体形成術は骨粗鬆症性骨折の治療において優れた結果を示していますが、悪性病変や衝撃の強い外傷による骨折に対する有効性は現在も調査中であり、患者の正確な評価と個別の治療計画の必要性が強調されています。

椎体形成術と他の治療法との比較は？

椎体形成術は、そのユニークな利点から、特定のタイプの椎体圧迫骨折に対する好ましい治療法として際立っていますが、しばしば、それぞれ長所と限界のある、カイフォプラスティや脊椎固定術のような他の治療法と比較されます。関連手術であるカイフォプラスティは、セメントを注入する前に、バルーンタンピングを使用して椎骨内に空洞を作り、失われた椎骨の高さをある程度回復させ、脊椎の変形を矯正するのに役立ちます。脊椎の湾曲を抑え、姿勢の異常を予防する上で、骨端形成術はより効果的であるが、一般的に椎体形成術よりも費用と時間がかかります。対照的に、椎体形成術はセメントを直接注入するため、より簡単で、より早く、より安価です。脊椎固定術は、より侵襲的な外科的選択肢であり、通常、複数の椎骨を含む重篤な症例や、脊椎が著しく不安定な場合にのみ行われます。この手術では、2つ以上の椎骨を永久的に結合させるために、骨移植と金属製の金具を使用するため、複雑さ、回復時間、合併症の可能性が高くなります。椎体形成術は低侵襲性であるため、局所麻酔で行われ、多くの場合外来患者として行われるため、侵襲性の高い手術に必要な長時間の麻酔や入院に耐えられない高齢者や医学的に脆弱な患者にとって理想的な選択肢となります。さらに、椎体形成術による疼痛の緩和と骨折の安定化の成功率は、より侵襲的な手技に匹敵するか、それ以上であるため、特に迅速な疼痛の緩和と正常な機能への復帰が第一の治療目標である場合には、非常に有利な選択肢となります。しかし、これらの選択肢の選択は、椎体崩壊の程度、全体的な骨の健康状態、各治療法のリスクとベネフィットを十分に議論した後の患者固有の嗜好など、様々な要因に左右されます。

椎体形成術の成長を形作る市場力学とは？

椎体形成術市場の成長は、骨粗鬆症とそれに関連する椎体骨折の有病率の上昇、処置技術の進歩、侵襲性の低い治療オプションへの患者の嗜好の変化など、いくつかの要因によってもたらされます。骨粗鬆症は高齢者、特に閉経後の女性に特に多く、椎体圧迫骨折の治療を必要とする患者数の急増につながるため、世界の高齢化は椎体形成術の需要を牽引する重要な要因です。さらに、生体活性セメントや放射線不透過性セメントなどの革新的なセメント製剤のイントロダクションより、手技の安全性と治療成績が改善され、椎体形成術は患者と医療従事者の双方にとってより魅力的な選択肢となっています。さらに、高精細透視やリアルタイムの3D画像の採用を含む画像診断技術の向上により、手技の精度が向上し、合併症やセメント漏れのリスクが減少しています。また、外来や外来手術への嗜好が高まっていることも、市場拡大に寄与しています。椎体形成術は、長期入院の必要なく実施できることが多いため、全体的なヘルスケアコストを削減し、患者の満足度を高めています。消費者の行動動向は、回復が早く日常生活への支障が少ない治療に対する需要の高まりを示し、椎体形成術の採用をさらに後押ししています。脊椎骨折に対する早期介入の利点に関するヘルスケア専門家や患者の意識の高まりは、より積極的な治療戦略につながり、潜在的な患者層を拡大しています。さらに、新たな市場プレイヤーの参入や主要利害関係者間の戦略的パートナーシップにより、競合が活性化し、イノベーションが促進され、椎体形成術がより利用しやすくなり、コストが低下すると予想されます。その結果、椎体形成術市場は、人口動向、技術革新、患者や医療提供者の嗜好の進化に支えられ、今後数年間で力強い成長を遂げるものと思われます。

調査対象企業の例（全42件）

  • Alphatec Spine, Inc.
  • DePuy Synthes（Johnson & Johnson）
  • Globus Medical, Inc.
  • IZI Medial Products
  • Medtronic
  • Merit Medical Systems, Inc.
  • Rontis
  • SPINUS（BMK Global Medical Company）
  • Stryker Corporation
  • Zavation

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • スペイン
  • ロシア
  • その他欧州
  • アジア太平洋
  • オーストラリア
  • インド
  • 韓国
  • その他アジア太平洋地域
  • ラテンアメリカ
  • アルゼンチン
  • ブラジル
  • メキシコ
  • その他ラテンアメリカ
  • 中東
  • イラン
  • イスラエル
  • サウジアラビア
  • アラブ首長国連邦
  • その他中東
  • アフリカ

第4章 競合

目次
Product Code: MCP17642

Global Vertebroplasty Market to Reach US$426.7 Million by 2030

The global market for Vertebroplasty estimated at US$287.5 Million in the year 2023, is expected to reach US$426.7 Million by 2030, growing at a CAGR of 5.8% over the analysis period 2023-2030.

The U.S. Market is Estimated at US$76.3 Million While China is Forecast to Grow at 8.5% CAGR

The Vertebroplasty market in the U.S. is estimated at US$76.3 Million in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$95.3 Million by the year 2030 trailing a CAGR of 8.5% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 3.3% and 5.5% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 3.4% CAGR.

Global Vertebroplasty Market - Key Trends and Drivers Summarized

What Is Vertebroplasty and How Does It Work?

Vertebroplasty is a cutting-edge, minimally invasive surgical procedure developed to treat painful vertebral compression fractures (VCFs) caused primarily by osteoporosis, metastatic cancers, or trauma. This procedure entails injecting a specialized acrylic bone cement, most commonly polymethylmethacrylate (PMMA), directly into the fractured vertebra to stabilize it and provide rapid pain relief. During vertebroplasty, the surgeon carefully inserts a thin needle through the skin into the fractured bone under continuous real-time fluoroscopic or CT imaging guidance to ensure precise placement of the cement. The cement is injected in a semi-liquid state and quickly hardens inside the vertebra, effectively restoring its structural integrity and reducing micromovements that are the source of pain. What makes vertebroplasty especially appealing is its ability to provide immediate and lasting pain relief, allowing patients to resume normal activities shortly after the procedure. It is typically recommended for patients who have not responded to conservative management, such as bed rest, pain medication, and bracing, making it a critical option for improving the quality of life in individuals with debilitating spinal fractures. Additionally, vertebroplasty has a well-established safety profile, and recent advancements in imaging techniques, cement composition, and procedural methodologies have significantly reduced the associated risks, making it a widely accepted therapeutic option in the orthopedic and neurosurgical communities.

What Are the Major Benefits and Challenges of Vertebroplasty?

The advantages of vertebroplasty are multifaceted, providing substantial clinical benefits to patients with vertebral compression fractures, yet the procedure is not without its challenges. One of its primary benefits is the rapid and significant reduction of pain, which often occurs within hours post-procedure, enabling patients to regain mobility and return to their daily routines much faster than traditional open surgical treatments. This accelerated recovery is particularly crucial for elderly patients with limited physical capacity and those who suffer from multiple comorbidities that complicate their treatment. Furthermore, by stabilizing the fractured vertebra, vertebroplasty prevents further collapse and deformation of the spine, reducing the risk of progressive kyphosis, commonly known as a "dowager’s hump." Despite these benefits, vertebroplasty has sparked considerable debate in the medical community, primarily due to concerns regarding cement leakage—a complication that occurs when the injected material extrudes from the vertebral body into adjacent structures, potentially causing nerve root compression, embolism, or spinal cord injury. To mitigate these risks, there have been advancements in cement formulations, including the use of higher viscosity cements and refined injection techniques that allow for better control during the procedure. Another significant challenge lies in the selection of appropriate candidates for vertebroplasty, as its efficacy varies depending on the underlying cause of the fracture. While it has shown excellent outcomes in treating osteoporotic fractures, its effectiveness in fractures caused by malignant lesions or high-impact trauma remains a subject of ongoing research, highlighting the need for precise patient evaluation and individualized treatment planning.

How Does Vertebroplasty Compare to Other Treatment Options?

Vertebroplasty stands out as a preferred treatment for certain types of vertebral compression fractures due to its unique benefits, but it is often compared to other procedures like kyphoplasty and spinal fusion, each of which has its own strengths and limitations. Kyphoplasty, a related procedure, involves the use of a balloon tamp to create a cavity within the vertebra before cement is injected, which helps to restore some of the lost vertebral height and correct spinal deformity. While kyphoplasty is more effective in reducing spinal curvature and preventing postural abnormalities, it is typically more expensive and time-consuming than vertebroplasty. Vertebroplasty, by contrast, involves direct cement injection, making it simpler, faster, and less costly. Spinal fusion, a more invasive surgical option, is usually reserved for severe cases involving multiple vertebrae or when there is significant spinal instability. This procedure involves placing bone grafts and metallic hardware to permanently join two or more vertebrae, which increases the complexity, recovery time, and the potential for complications. Due to its minimally invasive nature, vertebroplasty is performed under local anesthesia and often as an outpatient procedure, making it an ideal choice for elderly or medically fragile patients who cannot tolerate the prolonged anesthesia or hospitalization required for more invasive surgeries. Moreover, vertebroplasty’s success rate in alleviating pain and stabilizing the fracture is comparable to or even exceeds that of more invasive techniques, making it a highly favorable option, especially when quick pain relief and a return to normal function are primary treatment goals. However, the choice between these options depends on various factors such as the degree of vertebral collapse, overall bone health, and patient-specific preferences following a thorough discussion of the risks and benefits of each treatment modality.

What Are the Market Dynamics Shaping Vertebroplasty Growth?

The growth in the vertebroplasty market is driven by several factors, including the rising prevalence of osteoporosis and related vertebral fractures, advancements in procedural technology, and shifting patient preferences towards less invasive treatment options. The global aging population is a key driver of demand for vertebroplasty, as osteoporosis is particularly prevalent among older adults, especially postmenopausal women, leading to a surge in the number of patients requiring treatment for vertebral compression fractures. Furthermore, the introduction of innovative cement formulations, such as bioactive and radiopaque cements, has improved procedural safety and outcomes, making vertebroplasty a more attractive option for both patients and healthcare providers. Additionally, improvements in imaging techniques, including the adoption of high-definition fluoroscopy and real-time 3D imaging, have enhanced procedural precision, reducing the risk of complications and cement leakage. The growing preference for outpatient and ambulatory surgical settings has also contributed to the market expansion, as vertebroplasty can often be performed without the need for prolonged hospitalization, thereby reducing overall healthcare costs and increasing patient satisfaction. Consumer behavior trends indicate a rising demand for treatments that offer rapid recovery and minimal disruption to daily life, further fueling the adoption of vertebroplasty. Increased awareness among healthcare professionals and patients about the benefits of early intervention for spinal fractures has led to more proactive treatment strategies, expanding the potential patient base. Furthermore, the entry of new market players and strategic partnerships among key stakeholders are expected to boost competition, foster innovation, and drive down costs, making vertebroplasty more accessible. As a result, the vertebroplasty market is poised for robust growth in the coming years, supported by a combination of demographic trends, technological innovations, and evolving patient and provider preferences.

Select Competitors (Total 42 Featured) -

  • Alphatec Spine, Inc.
  • DePuy Synthes (Johnson & Johnson)
  • Globus Medical, Inc.
  • IZI Medial Products
  • Medtronic
  • Merit Medical Systems, Inc.
  • Rontis
  • SPINUS (BMK Global Medical Company)
  • Stryker Corporation
  • Zavation

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Global Economic Update
    • Vertebroplasty - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Growing Prevalence of Spinal Compression Fractures Accelerates Vertebroplasty Adoption
    • Rising Geriatric Population Spurs Demand for Vertebroplasty Procedures
    • Increased Awareness of Minimally Invasive Spine Treatments Expands Market Opportunities
    • Advancements in Imaging Technology Drive Adoption of Precision-Guided Vertebroplasty
    • Shift Towards Minimally Invasive Techniques Over Traditional Open Surgeries Fuels Market Growth
    • Increasing Focus on Outpatient Settings Expands Market Reach for Vertebroplasty Services
    • Innovations in Bioactive Bone Cements Generate New Product Demand
    • Growing Popularity of Personalized, Patient-Specific Solutions Propels Market Expansion
    • Heightened Need for Effective Pain Management in Oncology Patients Increases Vertebroplasty Utilization
    • Wider Physician Training Programs Enhance Market Penetration of Vertebroplasty Procedures
    • Patient Preference for Shorter Recovery Time and Minimally Invasive Options Drives Adoption
    • Surging Healthcare Investments in Emerging Markets Open New Growth Opportunities
    • High Costs and Risk of Procedure-Related Complications Present Market Challenges
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Vertebroplasty by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 2: World Historic Review for Vertebroplasty by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 3: World 16-Year Perspective for Vertebroplasty by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2024 & 2030
    • TABLE 4: World Vertebroplasty Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Vertebroplasty Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 5: USA Recent Past, Current & Future Analysis for Vertebroplasty by Segment - Vertebroplasty - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 6: USA Historic Review for Vertebroplasty by Segment - Vertebroplasty Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • CANADA
    • TABLE 7: Canada Recent Past, Current & Future Analysis for Vertebroplasty by Segment - Vertebroplasty - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 8: Canada Historic Review for Vertebroplasty by Segment - Vertebroplasty Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • JAPAN
    • Vertebroplasty Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 9: Japan Recent Past, Current & Future Analysis for Vertebroplasty by Segment - Vertebroplasty - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 10: Japan Historic Review for Vertebroplasty by Segment - Vertebroplasty Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • CHINA
    • Vertebroplasty Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 11: China Recent Past, Current & Future Analysis for Vertebroplasty by Segment - Vertebroplasty - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 12: China Historic Review for Vertebroplasty by Segment - Vertebroplasty Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • EUROPE
    • Vertebroplasty Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 13: Europe Recent Past, Current & Future Analysis for Vertebroplasty by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 14: Europe Historic Review for Vertebroplasty by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 15: Europe 16-Year Perspective for Vertebroplasty by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2024 & 2030
  • FRANCE
    • Vertebroplasty Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 16: France Recent Past, Current & Future Analysis for Vertebroplasty by Segment - Vertebroplasty - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 17: France Historic Review for Vertebroplasty by Segment - Vertebroplasty Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • GERMANY
    • Vertebroplasty Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 18: Germany Recent Past, Current & Future Analysis for Vertebroplasty by Segment - Vertebroplasty - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 19: Germany Historic Review for Vertebroplasty by Segment - Vertebroplasty Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • ITALY
    • TABLE 20: Italy Recent Past, Current & Future Analysis for Vertebroplasty by Segment - Vertebroplasty - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 21: Italy Historic Review for Vertebroplasty by Segment - Vertebroplasty Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • UNITED KINGDOM
    • Vertebroplasty Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 22: UK Recent Past, Current & Future Analysis for Vertebroplasty by Segment - Vertebroplasty - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 23: UK Historic Review for Vertebroplasty by Segment - Vertebroplasty Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • SPAIN
    • TABLE 24: Spain Recent Past, Current & Future Analysis for Vertebroplasty by Segment - Vertebroplasty - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 25: Spain Historic Review for Vertebroplasty by Segment - Vertebroplasty Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • RUSSIA
    • TABLE 26: Russia Recent Past, Current & Future Analysis for Vertebroplasty by Segment - Vertebroplasty - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 27: Russia Historic Review for Vertebroplasty by Segment - Vertebroplasty Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • REST OF EUROPE
    • TABLE 28: Rest of Europe Recent Past, Current & Future Analysis for Vertebroplasty by Segment - Vertebroplasty - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 29: Rest of Europe Historic Review for Vertebroplasty by Segment - Vertebroplasty Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • ASIA-PACIFIC
    • Vertebroplasty Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 30: Asia-Pacific Recent Past, Current & Future Analysis for Vertebroplasty by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 31: Asia-Pacific Historic Review for Vertebroplasty by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 32: Asia-Pacific 16-Year Perspective for Vertebroplasty by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2024 & 2030
  • AUSTRALIA
    • Vertebroplasty Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2024 (E)
    • TABLE 33: Australia Recent Past, Current & Future Analysis for Vertebroplasty by Segment - Vertebroplasty - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 34: Australia Historic Review for Vertebroplasty by Segment - Vertebroplasty Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • INDIA
    • Vertebroplasty Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2024 (E)
    • TABLE 35: India Recent Past, Current & Future Analysis for Vertebroplasty by Segment - Vertebroplasty - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 36: India Historic Review for Vertebroplasty by Segment - Vertebroplasty Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • SOUTH KOREA
    • TABLE 37: South Korea Recent Past, Current & Future Analysis for Vertebroplasty by Segment - Vertebroplasty - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 38: South Korea Historic Review for Vertebroplasty by Segment - Vertebroplasty Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • REST OF ASIA-PACIFIC
    • TABLE 39: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Vertebroplasty by Segment - Vertebroplasty - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 40: Rest of Asia-Pacific Historic Review for Vertebroplasty by Segment - Vertebroplasty Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • LATIN AMERICA
    • Vertebroplasty Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2024 (E)
    • TABLE 41: Latin America Recent Past, Current & Future Analysis for Vertebroplasty by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 42: Latin America Historic Review for Vertebroplasty by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 43: Latin America 16-Year Perspective for Vertebroplasty by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2024 & 2030
  • ARGENTINA
    • TABLE 44: Argentina Recent Past, Current & Future Analysis for Vertebroplasty by Segment - Vertebroplasty - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 45: Argentina Historic Review for Vertebroplasty by Segment - Vertebroplasty Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • BRAZIL
    • TABLE 46: Brazil Recent Past, Current & Future Analysis for Vertebroplasty by Segment - Vertebroplasty - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 47: Brazil Historic Review for Vertebroplasty by Segment - Vertebroplasty Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • MEXICO
    • TABLE 48: Mexico Recent Past, Current & Future Analysis for Vertebroplasty by Segment - Vertebroplasty - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 49: Mexico Historic Review for Vertebroplasty by Segment - Vertebroplasty Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • REST OF LATIN AMERICA
    • TABLE 50: Rest of Latin America Recent Past, Current & Future Analysis for Vertebroplasty by Segment - Vertebroplasty - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 51: Rest of Latin America Historic Review for Vertebroplasty by Segment - Vertebroplasty Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • MIDDLE EAST
    • Vertebroplasty Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2024 (E)
    • TABLE 52: Middle East Recent Past, Current & Future Analysis for Vertebroplasty by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 53: Middle East Historic Review for Vertebroplasty by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 54: Middle East 16-Year Perspective for Vertebroplasty by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2024 & 2030
  • IRAN
    • TABLE 55: Iran Recent Past, Current & Future Analysis for Vertebroplasty by Segment - Vertebroplasty - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 56: Iran Historic Review for Vertebroplasty by Segment - Vertebroplasty Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • ISRAEL
    • TABLE 57: Israel Recent Past, Current & Future Analysis for Vertebroplasty by Segment - Vertebroplasty - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 58: Israel Historic Review for Vertebroplasty by Segment - Vertebroplasty Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • SAUDI ARABIA
    • TABLE 59: Saudi Arabia Recent Past, Current & Future Analysis for Vertebroplasty by Segment - Vertebroplasty - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 60: Saudi Arabia Historic Review for Vertebroplasty by Segment - Vertebroplasty Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • UNITED ARAB EMIRATES
    • TABLE 61: UAE Recent Past, Current & Future Analysis for Vertebroplasty by Segment - Vertebroplasty - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 62: UAE Historic Review for Vertebroplasty by Segment - Vertebroplasty Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • REST OF MIDDLE EAST
    • TABLE 63: Rest of Middle East Recent Past, Current & Future Analysis for Vertebroplasty by Segment - Vertebroplasty - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 64: Rest of Middle East Historic Review for Vertebroplasty by Segment - Vertebroplasty Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • AFRICA
    • Vertebroplasty Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2024 (E)
    • TABLE 65: Africa Recent Past, Current & Future Analysis for Vertebroplasty by Segment - Vertebroplasty - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 66: Africa Historic Review for Vertebroplasty by Segment - Vertebroplasty Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR

IV. COMPETITION